Ambev SA ADRABEV
Price$2.92Intrinsic value$1.4650% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $16.1B+11.4% YoYTTM through 31 Dec 2025
Net Income $2.8B+21.3% YoYTTM through 31 Dec 2025
Free Cash Flow $3.6BTTM through 31 Dec 2025

Margins

Current
Operating Margin26.4%
Net Margin17.6%

Returns

17.5%ROE
10.7%ROA

Balance Sheet Health

Current Ratio0.96x
Cash & Equivalents$18.6B

Quality Metrics

Piotroski F-Score6 / 9
FCF Margin22.5%
Rule of 4025.4
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $88.2B
Diluted EPS
'19'20'21'22'23'24'25
FY2025: $0.99

Dividend

$0.01Per share, FY20260.30%Yield-40.7%5-yr growth

Capital Allocation

Capex Intensity28.5%
Financials converted at 5.4762 from BRL.
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.